Urocortin: a few inflammatory remarks.
Davidson
Sean M
SM
Division of Medicine, Royal Free and University College Medical School, The Hatter Cardiovascular Institute, London WC1E 6HX, United Kingdom. s.davidson@ucl.ac.uk
Yellon
Derek M
DM
D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects / Q000502:physiology*; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism*; D048031:JNK Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D008070:Lipopolysaccharides / Q000633:toxicity; D008643:Mesentery / Q000098:blood supply*; D008954:Models, Biological; D051381:Rats; D017207:Rats, Sprague-Dawley; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D054832:Urocortins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D000099052:CRF Receptor, Type 1
D008070:Lipopolysaccharides; D018019:Receptors, Corticotropin-Releasing Hormone; D054832:Urocortins; D000099052:CRF Receptor, Type 1; D048031:JNK Mitogen-Activated Protein Kinases